News

Cicor Optimizes Thin-Film Production Operations in Switzerland

Cicor Optimizes Thin-Film Production Operations in Switzerland

Cicor Group's Strategic Production Consolidation

Cicor Group has announced an important step towards streamlining its operations by centralizing thin-film production at its facility in Wangs, Switzerland. This strategic decision, aimed at increasing operational efficiency, will result in the discontinuation of production at the existing site in Ulm, Germany, by mid-2025. As a frontrunner in hybrid circuit manufacturing in Europe, Cicor is committed to innovating and optimizing its processes to better serve its clients.

Reasons Behind the Production Shift

The decision to consolidate production is driven by several factors. Reinhardt Microtech AG, which has been a part of Cicor since 2007, has been managing the Ulm facility since it acquired its thin-film business in 1998. The company emphasized that reducing operational complexity while enhancing flexibility and risk management were primary motives for this change. Despite both locations having the capability to produce the same components, maintaining operations in both places proved economically unviable.

Impact on Employees

This decision will directly affect around 30 employees currently working in Ulm, with their positions set to conclude by June 30, 2025. To support these employees during this transition, Cicor has proposed opportunities for relocation to the Wangs site or alternative sales roles in the Ulm area. The company values its employees and is dedicated to providing options to ease the shifting circumstances.

Future Outlook for Cicor

While this consolidation is expected to have a temporary impact on Cicor Group’s EBITDA, anticipated to be a six-figure sum in Swiss francs in the current fiscal year, the long-term prospects remain bright. The company believes that post-relocation, there will be significant improvements in the performance of the Advanced Substrates Division. Importantly, Cicor assured stakeholders that the restructuring will not alter its guidance for 2024 or its mid-term strategic objectives.

Commitment to Customers

Despite the closure of the Ulm production site, Reinhardt Microtech GmbH will continue to operate in Ulm as a sales and competence center. This will allow Cicor to maintain high-quality service for its established German customer base. The firm is dedicated to ensuring that customer support and service continue uninterrupted during this transition period.

Conclusion

The consolidation of thin-film production in Switzerland is a crucial step for Cicor Group as it seeks to optimize operations and remain competitive in the hybrid circuit manufacturing sector. This move reflects the company’s commitment to efficiency and excellence in service delivery, which are essential in today’s dynamic market environment. As Cicor embarks on this new chapter, it remains focused on its strategic objectives, ensuring that both its employees and customers are well taken care of during these changes.

Frequently Asked Questions

What is Cicor Group's recent announcement about?

Cicor Group announced its plans to centralize thin-film production in Switzerland, discontinuing operations in Ulm, Germany.

Why is Cicor consolidating its production?

The consolidation aims to reduce operational complexity, enhance flexibility, and improve risk management.

How will employees be affected by this decision?

Approximately 30 employees will be affected, with opportunities for relocation or alternative roles offered to them.

What will happen to the Ulm facility?

Reinhardt Microtech GmbH will maintain its presence in Ulm as a sales and competence center.

What does this mean for Cicor's financial outlook?

While there may be a short-term negative impact on EBITDA, the consolidation is expected to enhance overall performance in the future.

About The Author

About Investors Hangout

Investors Hangout is a leading online stock forum for financial discussion and learning, offering a wide range of free tools and resources. It draws in traders of all levels, who exchange market knowledge, investigate trading tactics, and keep an eye on industry developments in real time. Featuring financial articles, stock message boards, quotes, charts, company profiles, and live news updates. Through cooperative learning and a wealth of informational resources, it helps users from novices creating their first portfolios to experts honing their techniques. Join Investors Hangout today: https://investorshangout.com/

The content of this article is based on factual, publicly available information and does not represent legal, financial, or investment advice. Investors Hangout does not offer financial advice, and the author is not a licensed financial advisor. Consult a qualified advisor before making any financial or investment decisions based on this article. This article should not be considered advice to purchase, sell, or hold any securities or other investments. If any of the material provided here is inaccurate, please contact us for corrections.

Top 10 Most Recent News Articles

Synagro Technologies Faces Lawsuit Over Unpaid Expenses

Updated Category News Views 6

Another Day, Another Lawsuit in Corporate America When it rains, it pours, especially in the corporate world where companies occasionally seem to forget they're playing with other people's livelihoods. Now, it's Synagro Technologies, Inc. facing the music. The company is under fire from Blumenthal Nordrehaug Bhowmik De Blouw LLP, a law firm well-versed in employee rights...

Continue Reading
Quay Shines in 2026 Prescription Sunglasses Lineup

Updated Category News Views 5

Spotlight on Quay: A Fashion-Forward Prescription Glasses that make you look good and actually correct your vision? That's the holy grail right there. Consumer365 just put Quay front and center in their 2026 rundown of the best prescription sunglasses out there. Let's break this down and see what's got folks buzzing. Diving into Style and Substance Now, if you're like me,...

Continue Reading
Revamping Children's Radiotherapy: Leo Cancer Care's Vision

Updated Category News Views 5

The latest buzz in pediatric radiotherapy is shaking things up, and it’s all thanks to a game-changing shift in how treatment is delivered to kids. We're eyeballing Leo Cancer Care's innovative approach that might just redefine how these young patients face their battles. Standing Tall: A New Chapter in Proton Therapy In June, Stanford Medicine dished out the first...

Continue Reading
DKS Facing Class Action Over Stock Slump Allegations

Updated Category News Views 3

A Burst Bubble at DICK'S Sporting Goods Grit your teeth and hang on—DICK'S Sporting Goods has stumbled, and investors are supposed to just weather the storm. From September 8, 2025, through August 24, 2026, if you held DICK'S shares, you've got some explaining to do, or at least you better start reading the fine print. Take note, folks: the deadline to file for lead...

Continue Reading
Leo Cancer Care's Upright Radiotherapy Milestone

Updated Category News Views 4

Upright Radiotherapy: Breaking Tradition in Cancer Care Here's a twist in the world of cancer treatment folks weren't exactly expecting. Leo Cancer Care has flipped the script by taking radiotherapy from a concept to an actual clinical reality with their Upright Platform. Yes, we're talking about standing up while getting treated, and it's not just a gimmick—it's a game...

Continue Reading
Fuse Oncology Showcases New iRT Workflow at ASTRO

Updated Category News Views 4

Revolutionizing Charge Capture in Oncology Fuse Oncology's latest showcase at the ASTRO 2026 Annual Meeting isn't just about flashy presentations—it's looking to change how radiation oncology departments handle complex workflows. If you've ever delved into the maze of oncology billing, you know it's rife with opportunities for errors and inefficiencies. Skip one charge,...

Continue Reading
Accuray, Samsung Push Boundaries with Imaging Deal

Updated Category News Views 3

In a move that's got the healthcare industry buzzing, Accuray Incorporated (NASDAQ: ARAY) announced its partnership with Samsung NeuroLogica to supercharge the CyberKnife® System. This isn't just another collaboration; it's a strategic pivot to advance imaging capabilities, marrying Samsung's volumetric innovations with Accuray's established precision in robotic...

Continue Reading
Melrose Fire Station Reaches Steel Topping Milestone

Updated Category News Views 3

Metal and Milestones: A New Era for Melrose Rolling into Melrose, Massachusetts, there's some serious action kicking off with the new Fire Engine 2 Station reaching a steel topping milestone. This phase isn't just about slapping on another beam; it's the crescendo of diligent teamwork from all the hands involved—from CTA Construction Managers to the clout of Ironworkers...

Continue Reading
AI Memory Growth Pushes Limits at GMIF2026 Summit

Updated Category News Views 3

The Memory and Storage Race in the AI Era The 5th GMIF2026 Innovation Summit wrapped up in Shenzhen, and boy, was it a heavyweight bout. You could practically feel the tension in the room as industry giants sparred over the future of memory and storage in AI. This wasn't just another trade show pow-wow; this was a strategic chess match over where AI infrastructure is...

Continue Reading
IASO's FUCASO Shows Robust Results in 2026 Study

Updated Category News Views 6

IASO's Groundbreaking Results Stir Ripples in Oncology Folks, let me paint the picture here with the mighty, nitty-gritty details straight from the heart of China. The 2026 IMS Annual Meeting held a gem that could redefine how investors see the course of hematologic malignancy treatments. IASO Bio dropped some heavy data, showing their fine product, FUCASO, in a...

Continue Reading

Top 5 Most Recently Viewed Articles

Understanding Your Rights as a Humacyte, Inc. Investor

Updated Category News Views 110

Understanding Your Rights as a Humacyte, Inc. Investor Humacyte, Inc. (NASDAQ: HUMA) has recently captured the attention of investors due to certain legal developments affecting its share value. If you are a shareholder who purchased shares during the specific class period of May 10, 2024, to October 17, 2024, you may want to take active steps to protect your investment...

Continue Reading
Jim Chanos Raises Concerns About Oracle's Accounting Issues

Updated Category News Views 552

Chanos Questions Oracle's Accounting Practices Notable short-seller Jim Chanos has recently highlighted some serious concerns regarding Oracle Corp's accounting integrity. He has voiced skepticism about the company's massive project backlog, especially a significant $300 billion deal partnered with OpenAI, emphasizing that its operational realization is years away and...

Continue Reading
Cyrus Biotechnology Advances Novel IgG Therapy with No Antibodies

Updated Category News Views 171

Promising Developments by Cyrus Biotechnology Cyrus Biotechnology, Inc. has unveiled groundbreaking data showcasing the effectiveness of its engineered IgG-degrading enzyme, CYR241, in a unique rabbit redosing model. This enzyme demonstrates significant therapeutic activity without the formation of anti-drug antibodies (ADAs) upon repeated administration. Understanding...

Continue Reading
GreenPower Motor Company: Strengthening Its Financial Future

Updated Category News Views 241

GreenPower Motor Company Secures New Term Loan Funding GreenPower Motor Company Inc. (NASDAQ: GP), an innovator in the production and distribution of all-electric medium and heavy-duty vehicles, recently completed the closing of the fifth tranche of its secured term loan offering. This strategic move aims to bolster its operational capabilities, particularly in the cargo,...

Continue Reading
Unlocking the Future: Insights into the Cloud Industry 2025

Updated Category News Views 226

The Promising Future of the Global Cloud Industry The global cloud industry is on a fast track to remarkable growth. Recent research indicates that the market is poised to expand from approximately USD 1,091.4 billion in one year to an impressive USD 1,256.8 billion by 2025. This represents a noteworthy year-over-year increase of about 15.1%. With such staggering figures,...

Continue Reading